{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T19:36:48Z","timestamp":1772653008448,"version":"3.50.1"},"reference-count":26,"publisher":"Public Library of Science (PLoS)","issue":"3","license":[{"start":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T00:00:00Z","timestamp":1772582400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000024","name":"Canadian Institute for Health Research","doi-asserted-by":"crossref","award":["CIHR: WI1-179883"],"award-info":[{"award-number":["CIHR: WI1-179883"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["www.plosglobalpublichealth.org"],"crossmark-restriction":false},"short-container-title":["PLOS Glob Public Health"],"abstract":"<jats:p>Sierra Leone is one of the 30 high TB burden countries in the world, with an incidence rate in 2023 of 273 per 100,000 population. Despite progress in case notification and treatment coverage, around 5,000 cases of TB in Sierra Leone are missing each year. The COVID-19 pandemic has further compounded these challenges. We highlight its effect on drug-resistant TB treatment outcomes. We conducted a retrospective cohort study of drug-resistant TB cases using national data from January 2017 to December 2022. Data was analyzed using STATA. Descriptive analysis summarized demographic, clinical characteristics and treatment outcomes. Logistic regression examined the association between time-period and outcomes, adjusting for age, gender, nutritional status, HIV status and regimen. Of 701 patients, 383 (54.6%) were registered pre-COVID-19, 228 (32.5%) during, and 92 (13.1%) post-COVID-19. Pre-treatment TB cases reduced from 359 (92.5%) in the pre-COVID-19 period to 80 (30.9%) in the COVID-19 period. New treatment cases increased from 29 (7.5%) to 159 (61.4%) during COVID-19. Treatment completion decreased from 74.7% pre-COVID-19 to 63.3% during and 68.5% post-COVID-19). Malnourished patients had higher odds of success (aOR: 1.482, 95% CI: 1.007-2.183), while those on short regimen had lower odds (aOR: 0.51, 95% CI: 0.321-0.810). We observed a decline in drug-resistant TB treatment success rate during COVID-19, which was primarily influenced by concurrent shifts in treatment protocols and underlying secular trends. The pandemic itself did not emerge as an independent determinant of poor treatment outcomes, highlighting the resilience of the TB care system. Nonetheless, the pandemic had significant indirect consequences, including worsening rates of malnutrition and HIV co-infection. These trends point to deeper systemic vulnerabilities, such as weak social protection mechanisms, increased food insecurity, and disruptions in HIV service delivery, all of which contributed to delay in diagnosis and compromised treatment adherence.<\/jats:p>","DOI":"10.1371\/journal.pgph.0004472","type":"journal-article","created":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T18:28:18Z","timestamp":1772648898000},"page":"e0004472","update-policy":"https:\/\/doi.org\/10.1371\/journal.pgph.corrections_policy","source":"Crossref","is-referenced-by-count":0,"title":["Effect of the COVID-19 pandemic on drug-resistant tuberculosis treatment outcomes at a national referral hospital in Sierra Leone, 2017 to 2022: A retrospective cohort study"],"prefix":"10.1371","volume":"6","author":[{"given":"Josephine Amie","family":"Koroma","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mariama","family":"Mahmoud","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9735-8038","authenticated-orcid":true,"given":"Bailah","family":"Molleh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephen","family":"Sevalie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adrienne K.","family":"Chan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8492-5470","authenticated-orcid":true,"given":"Sharmistha","family":"Mishra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7639-0004","authenticated-orcid":true,"given":"Sulaiman","family":"Lakoh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joseph Sam","family":"Kanu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2026,3,4]]},"reference":[{"key":"pgph.0004472.ref001","volume-title":"Global Tuberculosis Report 2020","author":"World Health Organization","year":"2020"},{"key":"pgph.0004472.ref002","volume-title":"Global Tuberculosis Report 2020","author":"World Health Organization","year":"2024"},{"issue":"6","key":"pgph.0004472.ref003","doi-asserted-by":"crossref","first-page":"547","DOI":"10.2174\/1568026621999201211200447","article-title":"Tuberculosis: An Update on Pathophysiology, Molecular Mechanisms of Drug Resistance, Newer Anti-TB Drugs, Treatment Regimens and Host- Directed Therapies","volume":"21","author":"P Borah","year":"2021","journal-title":"Curr Top Med Chem"},{"key":"pgph.0004472.ref004","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1007\/978-3-319-64371-7_11","article-title":"Epidemiology of Drug-Resistant Tuberculosis","volume":"1019","author":"AS Dean","year":"2017","journal-title":"Adv Exp Med Biol"},{"issue":"5","key":"pgph.0004472.ref005","doi-asserted-by":"crossref","DOI":"10.1016\/S2352-3018(20)30109-0","article-title":"Tuberculosis and HIV responses threatened by COVID-19","volume":"7","author":"P Adepoju","year":"2020","journal-title":"Lancet HIV"},{"key":"pgph.0004472.ref006","doi-asserted-by":"crossref","first-page":"3879","DOI":"10.2147\/IDR.S468985","article-title":"Assessment of Non-Adherence to Anti-TB Drugs and Associated Factors Among Patients Attending TB Treatment Centers During COVID-19 Pandemic in Mogadishu, Somalia: A Cross-Sectional Study","volume":"17","author":"AA Omar","year":"2024","journal-title":"Infect Drug Resist"},{"key":"pgph.0004472.ref007","doi-asserted-by":"crossref","first-page":"101235","DOI":"10.1016\/j.imu.2023.101235","article-title":"Mathematical modelling and analysis of COVID-19 and tuberculosis transmission dynamics","volume":"38","author":"R Singh","year":"2023","journal-title":"Inform Med Unlocked"},{"issue":"8","key":"pgph.0004472.ref008","doi-asserted-by":"crossref","first-page":"710","DOI":"10.5588\/ijtld.22.0006","article-title":"The COVID-19 and TB syndemic: the way forward","volume":"26","author":"A Trajman","year":"2022","journal-title":"Int J Tuberc Lung Dis"},{"issue":"3","key":"pgph.0004472.ref009","first-page":"154","article-title":"Impact of COVID-19 on Tuberculosis Case Detection and Treatment Outcomes in Sierra Leone","volume":"6","author":"S Lakoh","year":"2021","journal-title":"Trop Med Infect Dis"},{"issue":"43","key":"pgph.0004472.ref010","article-title":"Impact of COVID-19 Pandemic on the National PPM Tuberculosis Control Project in Korea: The Korean PPM Monitoring Database between July 2019 and June 2020","volume":"35","author":"J Min","year":"2020","journal-title":"J Korean Med Sci"},{"issue":"1","key":"pgph.0004472.ref011","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1080\/20469047.2020.1853350","article-title":"Global emerging resistance in pediatric infections with TB, HIV, and gram-negative pathogens","volume":"41","author":"LA Enane","year":"2021","journal-title":"Paediatr Int Child Health"},{"issue":"10","key":"pgph.0004472.ref012","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0311408","article-title":"Assessing the impact of COVID-19 on tuberculosis detection and treatment in healthcare facilities across Addis Ababa, Ethiopia: A comprehensive mixed-method, multi-center study","volume":"19","author":"BB Nasir","year":"2024","journal-title":"PLoS One"},{"issue":"4","key":"pgph.0004472.ref013","doi-asserted-by":"crossref","first-page":"343","DOI":"10.4103\/ijmy.ijmy_187_22","article-title":"Antibiotic resistance acquisition versus primary transmission in the presentation of extensively drug-resistant tuberculosis","volume":"11","author":"RF O\u2019Toole","year":"2022","journal-title":"Int J Mycobacteriol"},{"key":"pgph.0004472.ref014","article-title":"Accelerating development of new shorter TB treatment regimens in anticipation of a resurgence of multi-drug resistant TB due to the COVID-19 pandemic","author":"S Tiberi","year":"2021","journal-title":"Int J Infect Dis"},{"issue":"4","key":"pgph.0004472.ref015","first-page":"1","article-title":"Progress on diagnosis and treatment of drug-resistant tuberculosis in line with World Health Organization recommendations in six priority countries in the Western Pacific Region","volume":"13","author":"KH Oh","year":"2022","journal-title":"Western Pac Surveill Response J"},{"key":"pgph.0004472.ref016","volume-title":"WHO operational handbook on tuberculosis. Module 4: treatment - drug-resistant tuberculosis treatment, 2022 update","author":"World Health Organization","year":"2022"},{"key":"pgph.0004472.ref017"},{"issue":"2","key":"pgph.0004472.ref018","doi-asserted-by":"crossref","first-page":"205","DOI":"10.33073\/pjm-2022-018","article-title":"Prevalence and Drug Resistance Pattern of Mycobacterium tuberculosis Isolated from Tuberculosis Patients in Basra, Iraq","volume":"71","author":"KAS Mohammed","year":"2022","journal-title":"Pol J Microbiol"},{"key":"pgph.0004472.ref019","doi-asserted-by":"crossref","first-page":"2946","DOI":"10.3389\/fimmu.2018.02946","article-title":"The Wonder Years: What Can Primary School Children Teach Us About Immunity to Mycobacterium tuberculosis?","volume":"9","author":"JA Seddon","year":"2018","journal-title":"Front Immunol"},{"issue":"4","key":"pgph.0004472.ref020","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1111\/joim.13184","article-title":"The impact of novel coronavirus COVID-19 on noncommunicable disease patients and health systems: a review","volume":"289","author":"AY Chang","year":"2021","journal-title":"J Intern Med"},{"key":"pgph.0004472.ref021","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.2147\/JMDH.S448654","article-title":"Global Health Commodities Supply Chain in the Era of COVID-19 Pandemic: Challenges, Impacts, and Prospects: A Systematic Review","volume":"17","author":"ZT Mekonen","year":"2024","journal-title":"J Multidiscip Healthc"},{"issue":"1","key":"pgph.0004472.ref022","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1186\/s40795-023-00795-w","article-title":"Double burden of malnutrition among women in reproductive Age (15-49 years) in Sierra Leone: a secondary data analysis of the demographic health survey 2019 (SLDHS-2019)","volume":"9","author":"EN Ikoona","year":"2023","journal-title":"BMC Nutr"},{"issue":"2","key":"pgph.0004472.ref023","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.pulmoe.2020.12.012","article-title":"Tuberculosis and COVID-19 interaction: A review of biological, clinical and public health effects","volume":"27","author":"D Visca","year":"2021","journal-title":"Pulmonology"},{"key":"pgph.0004472.ref024","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.tifs.2021.12.003","article-title":"Impact of the COVID-19 pandemic on food production and animal health","volume":"121","author":"P Rahimi","year":"2022","journal-title":"Trends Food Sci Technol"},{"issue":"4","key":"pgph.0004472.ref025","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1007\/s10461-023-04149-2","article-title":"Impact of COVID-19 on the Utilization of HIV Testing and Linkage Services in Sierra Leone: Experience from Three Public Health Facilities in Freetown","volume":"28","author":"S Lakoh","year":"2024","journal-title":"AIDS Behav"},{"key":"pgph.0004472.ref026","first-page":"100159","article-title":"Impact of the COVID-19 pandemic on HIV testing rates across four geographically diverse urban centres in the United States: An observational study","volume":"7","author":"E Moitra","year":"2022","journal-title":"Lancet Reg Health Am"}],"container-title":["PLOS Global Public Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pgph.0004472","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T18:28:23Z","timestamp":1772648903000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pgph.0004472"}},"subtitle":[],"editor":[{"given":"Dione","family":"Benjumea-Bedoya","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2026,3,4]]},"references-count":26,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2026,3,4]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pgph.0004472","relation":{},"ISSN":["2767-3375"],"issn-type":[{"value":"2767-3375","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,4]]}}}